Surg-15. integrating molecular markers and extent of resection for risk stratification of patients with newly-diagnosed glioblastoma: a multicentre study

CONCLUSION:The combination of MGMT-M and EoR ≥ 95% is synergistic in improving patient survival, possibly reflecting the improved efficacy of chemotherapy at lower residual tumour volumes. Review of remaining cases and recursive partitioning analysis(RPA) are pending, and will allow development of an integrative risk stratification algorithm.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Sayeed, W., Batuyong, E., Li, H., Cadieux, M., Kelly, J., Scott, J., Semenchuk, J., Pitz, M., Easaw, J. Tags: SURGICAL THERAPY Source Type: research